Vijaypd Ceutical
Key Fundamentals
SMERetailConsumer ServicesPrice-based figures as of · TTM
- ROCE
- 11.60%
- Debt to Equity
- 0.64
- EPS (TTM)
- —
- Book Value
- ₹26.88
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 2.90
- ROE
- 11.90%
- Dividend Yield
- 0.00%
- EBITDA
- ₹8.80 Cr
- 52W High
- ₹114.50
- 52W Low
- ₹38.25
- Volume
- 0
Peer Comparison
Industrials › Retail › Pharmacy Retail › Heavy Electrical Equipment
| ₹423.85 | 51.25 | ₹1,46,351 Cr | 5.52 | 0.35% | 6.23% | 9.14% | ₹37,782 Cr | ₹2,878 Cr | |
| ₹6,750.00 | 47.87 | ₹1,40,908 Cr | 15.32 | 1.36% | 22.40% | 29.90% | ₹13,477 Cr | ₹2,988 Cr | |
| ₹841.45 | 96.28 | ₹1,27,312 Cr | 15.17 | 0.16% | 20.50% | 26.70% | ₹13,699 Cr | ₹1,364 Cr | |
| ₹29,100.00 | 112.75 | ₹1,24,045 Cr | 25.06 | 0.03% | 21.90% | 29.40% | ₹9,162 Cr | ₹1,149 Cr | |
| ₹3,509.00 | — | ₹1,22,035 Cr | 9.03 | 0.53% | 19.20% | 21.40% | ₹18,062 Cr | ₹3,276 Cr | |
| ₹4,265.00 | 83.66 | ₹1,04,523 Cr | 33.15 | 0.25% | 57.40% | 77.40% | ₹6,712 Cr | ₹1,305 Cr | |
| ₹2,963.00 | 70.90 | ₹1,01,562 Cr | 21.93 | 0.14% | 50.50% | 67.80% | ₹9,436 Cr | ₹1,489 Cr | |
| ₹78.00 | — | ₹154 Cr | 2.90 | 0.00% | 11.90% | 11.60% | — | — | |
| Median 8 companies | ₹3,236.00 | 77.28 | ₹1,23,040 Cr | 15.25 | 0.21% | 21.20% | 28.05% | ₹13,477 Cr | ₹1,489 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 81/100
Category scores
- Quality
- 36
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 33
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 34
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 52
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 56
- Good
- Trend strength, vol-adjusted 12% weight
- Ownership
- 58
- Good
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
5- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.4.02 Cr.
- Debtor days have increased from 88.6 to 111 days.
- Working capital days have increased from 24.4 days to 64.7 days
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Neutral | 6 | 7 | 6 |
| Oscillators | Bearish | 2 | 7 | 0 |
| Moving Averages | Strong Bullish | 4 | 0 | 6 |
Oscillators
Bearish
Overall
Neutral
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 49.19
- Neutral
- MACD (12,26,9)
- 0.86
- Bearish
- SMA (50)
- 73.11
- Bullish
- SMA (200)
- 70.87
- Bullish
As of
Growth Rate
From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 3Y | +24.65% |
|---|---|
| 1Y | −1.26% |
Net profit
| 3Y | +204.06% |
|---|---|
| 1Y | +7.43% |
Operating cash flow
| 3Y | Turned negative |
|---|---|
| 1Y | Outflow narrowed by ₹27.18 Cr |
Operating margin· change in pp
| 3Y | +2.18 pp |
|---|---|
| 1Y | −3.64 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2023 | ₹51.09 Cr |
|---|---|
| Mar 2024 | ₹59.15 Cr |
| Mar 2025 | ₹100 Cr |
| Mar 2026 | ₹98.96 Cr |
Net profit by year
| Mar 2023 | ₹0.18 Cr |
|---|---|
| Mar 2024 | ₹1.65 Cr |
| Mar 2025 | ₹4.71 Cr |
| Mar 2026 | ₹5.06 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 50.32 | 49.91 | 51.33 | 47.62 |
| Expenses | 44.84 | 46.99 | 46.97 | 47.27 |
| Operating Profit | 5.48 | 2.92 | 4.36 | 0.35 |
| OPM % | 10.89% | 5.85% | 8.49% | 0.73% |
| Other Income | 0.01 | 0.75 | 0.32 | 3.7 |
| Interest | 1.17 | 0.98 | 1.06 | 0.53 |
| Depreciation | 0.3 | 0.31 | 0.28 | 0.34 |
| PBT | 4.02 | 2.38 | 3.34 | 3.18 |
| Tax % | 26.62% | 26.05% | 27.84% | 16.67% |
| Net Profit | 2.95 | 1.76 | 2.42 | 2.64 |
| EPS (₹) | 4.21 | 1.25 | 1.73 | 1.35 |
Profit & Loss
₹ Cr| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 51.09 | 59.15 | 100 | 98.96 |
| Expenses | 49.77 | 54.27 | 91.8 | 94.25 |
| Operating Profit | 1.32 | 4.88 | 8.42 | 4.71 |
| OPM % | 2.58% | 8.25% | 8.4% | 4.76% |
| Other Income | 1.82 | 0 | 0.75 | 4.02 |
| Interest | 2.36 | 1.76 | 2.15 | 1.6 |
| Depreciation | 0.43 | 0.35 | 0.62 | 0.62 |
| PBT | 0.35 | 2.77 | 6.4 | 6.52 |
| Tax % | 48.57% | 40.43% | 26.41% | 22.39% |
| Net Profit | 0.18 | 1.65 | 4.71 | 5.06 |
| EPS (₹) | — | — | 3.36 | 2.59 |
| Div. Payout % | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 0 | 1 | 14.03 | 19.53 |
| Reserves | 4.93 | 5.59 | 18.39 | 33.01 |
| Borrowings | 25.57 | 24.45 | 21.77 | 33.67 |
| Other Liabilities | 2.37 | 2.23 | 3.09 | 10.1 |
| Total Liabilities | 32.87 | 33.27 | 57.28 | 96.31 |
| Fixed Assets | 2.73 | 2.43 | 8.74 | 8.72 |
| CWIP | 0 | 0 | 0.11 | 1.66 |
| Investments | 0.16 | 0.15 | 0.25 | 2.09 |
| Other Assets | 29.98 | 30.69 | 48.18 | 83.84 |
| Total Assets | 32.87 | 33.27 | 57.28 | 96.31 |
Cash Flow
₹ Cr| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | 0.3 | 2.93 | −34.5 | −7.32 |
| Investing | −0.09 | 12.78 | −9.72 | −12.17 |
| Financing | −0.18 | −1.86 | 47.32 | 25.37 |
| Net Cash Flow | 0.03 | 13.84 | 3.1 | 5.88 |
| Free Cash Flow | 0.28 | 2.87 | −43.97 | −9.46 |
| CFO/OP | 38 | 60 | −397 | −128 |
Ratios
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | 62.44 | 68.56 | 86.68 | 111 |
| Inventory Days | 30.97 | 28.85 | 47.61 | 46.48 |
| Days Payable | 15.44 | 5.13 | 8.09 | 31.77 |
| Cash Conversion Cycle | 77.96 | 92.29 | 126 | 125 |
| Working Capital Days | −83.94 | −60.1 | 68.65 | 64.69 |
| ROCE % | — | 14.75% | 20.06% | 11.57% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Vijaypd Ceutical insights
54 extracted metrics across FY23–FY26.
Documents
- 5 Oct 2026
- 2 Oct 2026
- 30 Sep 2026
Frequently Asked Questions about Vijaypd Ceutical
What does Vijaypd Ceutical Ltd do?
Where is Vijaypd Ceutical Ltd (VIJAYPD) listed?
Which sector does Vijaypd Ceutical Ltd belong to?
What is the 52-week high and low of Vijaypd Ceutical Ltd?
What is the Return on Equity (ROE) of Vijaypd Ceutical Ltd?
Company Information
Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/VIJAYPD.md for Vijaypd Ceutical Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.